Loss of ETHE1, a mitochondrial dioxygenase, causes fatal sulfide toxicity in ethylmalonic encephalopathy (Nature Medicine DOI: 10.1038/nm.1907);Loss of ETHE1, a mitochondrial dioxygenase, causes fatal sulfide toxicity in ethylmalonic encephalopathy

Nature Medicine

Volumn 15, Issue 2, 2009, Pages 200-205

  Tiranti, Valeria ^a   Viscomi, Carlo ^a   Hildebrandt, Tatjana ^b   Di Meo, Ivano ^a   Mineri, Rossana ^a   Tiveron, Cecilia ^c   D Levitt, Michael ^d   Prelle, Alessandro ^e   Fagiolari, Gigliola ^e   Rimoldi, Marco ^a   Zeviani, Massimo ^a  

^a DEPARTMENT OF NEUROSURGERY   (Italy)

^b HEINRICH HEINE UNIVERSITY   (Germany)

^c EUROPEAN BRAIN RESEARCH INSTITUTE   (Italy)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

^e FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME C OXIDASE; DIOXYGENASE; ETHE1 ENZYME; SULFIDE; THIOSULFATE; THIOSULFATE SULFURTRANSFERASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN DISEASE; CONTROLLED STUDY; ENZYME ANALYSIS; ESCHERICHIA COLI; ETHYLMALONIC ENCEPHALOPATHY; FATTY ACID OXIDATION; GENOTYPE; HELA CELL; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; MICROANGIOGRAPHY; MICROANGIOPATHY; MITOCHONDRION; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; URINALYSIS;

ESCHERICHIA COLI; EUKARYOTA; MUS;

EID: 59649121556     PISSN: 10788956     EISSN: 1546170X     Source Type: Journal    
DOI: 10.1038/nm0209-220b     Document Type: Erratum

References (39)

1. Burlina, A. et al. New clinical phenotype of branched-chain acyl-CoA oxidation defect. Lancet 338, 1522-1523 (1991).
2. Garcia-Silva, M.T. et al. Encephalopathy, petechiae, and acrocyanosis with ethylmalonic aciduria associated with muscle cytochrome c oxidase deficiency. J. Pediatr. 125, 843-844 (1994).
3. Gregersen, N. et al. Identification of four new mutations in the short-chain acyl-CoA dehydrogenase (SCAD) gene in two patients: one of the variant alleles, 511C → T, is present at an unexpectedly high frequency in the general population, as was the case for 625G → A, together conferring susceptibility to ethylmalonic aciduria. Hum. Mol. Genet. 7, 619-627 (1998).
4. Koeberl, D.D. et al. Rare disorders of metabolism with elevated butyryl- and isobutyryl-carnitine detected by tandem mass spectrometry newborn screening. Pediatr. Res. 54, 219-223 (2003).
5. Sass, J.O. et al. 2-Methylbutyryl-coenzyme A dehydrogenase deficiency: functional and molecular studies on a defect in isoleucine catabolism. Mol. Genet. Metab. 93, 30-35 (2008).
6. Vockley, J. & Ensenauer, R. Isovaleric acidemia: new aspects of genetic and phenotypic heterogeneity. Am. J. Med. Genet. C. Semin.Med. Genet. 142C, 95-103 (2006).
7. Tiranti, V. et al. Ethylmalonic encephalopathy is caused by mutations in ETHE1, a gene encoding a mitochondrial matrix protein. Am. J. Hum. Genet. 74, 239-252 (2004).
8. Tiranti, V. et al. ETHE1 mutations are specific to ethylmalonic encephalopathy. J. Med. Genet. 43, 340-346 (2006).
9. Mineri, R. et al. Identification of new mutations in the ETHE1 gene in a cohort of 14 patients presenting with ethylmalonic encephalopathy. J. Med. Genet. 45, 473-478 (2008).
10. Daiyasu, H., Osaka, K., Ishino, Y. & Toh, H. Expansion of the zinc metallo-hydrolase family of the β-lactamase fold. FEBS Lett. 503, 1-6 (2001).
11. Higashitsuji, H. et al. A novel protein overexpressed in hepatoma accelerates export of NF-κB from the nucleus and inhibits p53-dependent apoptosis. Cancer Cell 2, 335-346 (2002).
12. Higashitsuji, H. et al. Enhanced deacetylation of p53 by the anti-apoptotic protein HSCO in association with histone deacetylase 1. J. Biol. Chem. 282, 13716-13725 (2007).
13. Bensaad, K. & Vousden, K.H. p53: new roles in metabolism. Trends Cell Biol. 17, 286-291 (2007).
14. Psarra, A.M. & Sekeris, C.E. Nuclear receptors and other nuclear transcription factors in mitochondria: regulatory molecules in a new environment. Biochim. Biophys. Acta 1783, 1-11 (2008).
15. McCoy, J.G. et al. Structure of an ETHE1-like protein from Arabidopsis thaliana. Acta Crystallogr. D Biol. Crystallogr. 62, 964-970 (2006).
16. Szabo, C. Hydrogen sulphide and its therapeutic potential. Nat. Rev. Drug Discov. 6, 917-935 (2007).
17. Leschelle, X. et al. Adaptative metabolic response of human colonic epithelial cells to the adverse effects of the luminal compound sulfide. Biochim. Biophys. Acta 1725, 201-212 (2005).
18. Dorman, D.C. et al. Cytochrome oxidase inhibition induced by acute hydrogen sulfide inhalation: correlation with tissue sulfide concentrations in the rat brain, liver, lung, and nasal epithelium. Toxicol. Sci. 65, 18-25 (2002).
19. Garcia-Silva, M.T., Ribes, A., Campos, Y., Garavaglia, B. & Arenas, J.A. Syndrome of Encephalopathy, Petechiae, and Ethylmalonic Aciduria. Pediatric Neurology. 17, 165-170 (1997).
20. Furne, J., Springfield, J., Koenig, T., DeMaster, E. & Levitt, M.D. Oxidation of hydrogen sulfide and methanethiol to thiosulfate by rat tissues: a specialized function of the colonic mucosa. Biochem. Pharmacol. 62, 255-259 (2001).
21. Roediger, W.E., Moore, J. & Babidge, W. Colonic sulfide in pathogenesis and treatment of ulcerative colitis. Dig. Dis. Sci. 42, 1571-1579 (1997).
22. Hildebrandt, T.M. & Grieshaber, M.K. Three enzymatic activities catalyze the oxidation of sulfide to thiosulfate in mammalian and invertebrate mitochondria. FEBS J. 275, 3352-3361 (2008).
23. Goubern, M., Andriamihaja, M., Nubel, T., Blachier, F. & Bouillaud, F. Sulfide, the first inorganic substrate for human cells. FASEB J. 21, 1699-1706 (2007).
24. Theissen, U. & Martin, W. Sulfide:quinone oxidoreductase (SQR) from the lugworm Arenicola marina shows cyanide- and thioredoxin-dependent activity. FEBS J. 275, 1131-1139 (2008).
25. Bella, D.L. & Stipanuk, M.H. Effects of protein, methionine, or chloride on acid-base balance and on cysteine catabolism. Am. J. Physiol. 269, E910-E917 (1995).
26. Fernandez-Silva, P., Martinez-Azorin, F., Micol, V. & Attardi, G. The human mitochondrial transcription termination factor (mTERF) is a multizipper protein but binds to DNA as a monomer, with evidence pointing to intramolecular leucine zipper interactions. EMBO J. 16, 1066-1079 (1997).
27. Tiranti, V. et al. Identification of the gene encoding the human mitochondrial RNA polymerase (h-mtRPOL) by cyberscreening of the Expressed Sequence Tags database. Hum. Mol. Genet. 6, 615-625 (1997).
28. Moroni, I., D'Incerti, L., Farina, L., Rimoldi, M. & Uziel, G. Clinical, biochemical and neuroradiological findings in I-2-hydroxyglutaric aciduria. Neurol. Sci. 21, 103-108 (2000).
29. Di Donato, S. et al. Systemic carnitine deficiency due to lack of electron transfer flavoprotein:ubiquinone oxidoreductase. Neurology 36, 957-963 (1986).
30. Shih, V.E., Carney, M.M. & Mandell, R. A simple screening test for sulfite oxidase deficiency: detection of urinary thiosulfate by a modification of Sorbo's method. Clin. Chim. Acta 95, 143-145 (1979).
31. Linden, D.R. et al. Production of the gaseous signal molecule hydrogen sulfide in mouse tissues. J. Neurochem. 106, 1577-1585 (2008).
32. Furne, J., Saeed, A. & Levitt, M.D. Whole tissue hydrogen sulfide concentrations are orders of magnitude lower than presently accepted values. Am. J. Physiol. Regul. Integr. Comp. Physiol. 295, R1479-R1485 (2008).
33. Bennett, M.J. et al. Glutaric aciduria type II: biochemical investigation and treatment of a child diagnosed prenatally. J. Inherit. Metab. Dis. 7, 57-61 (1984).
34. Sciacco, M. & Bonilla, E. Cytochemistry and immunocytochemistry of mitochondria in tissue sections. Methods Enzymol. 264, 509-521 (1996).
35. Bugiani, M. et al. Clinical and molecular findings in children with complex I deficiency. Biochim. Biophys. Acta 1659, 136-147 (2004).
36. Sottocasa, G.L., Kuylenstierna, B., Ernster, L. & Bergstrand, A. An electron-transport system associated with the outer membrane of liver mitochondria. A biochemical and morphological study. J. Cell Biol. 32, 415-438 (1967).
37. Sörbo, B. Sulfate: turbidimetric and nephelometric methods. Methods Enzymol. 143, 3-6 (1987).
38. Sörbo, B. Rhodanese. Methods Enzymol. 2, 334-337 (1955).
39. 2+-dependent neurodegeneration in Surf1 knockout mice. Hum. Mol. Genet. 16, 431-444 (2007).